Response duration and survival shorten after each relapse in patients with follicular lymphoma treated in the rituximab era
A Rivas‐Delgado, L Magnano… - British journal of …, 2019 - Wiley Online Library
… -resistant behaviour, whereas in others the disease is indolent with durable remissions
after treatment. However, no plateau in the duration of response curves is observed. …
after treatment. However, no plateau in the duration of response curves is observed. …
Clinical outcomes in patients relapsed/refractory after≥ 2 prior lines of therapy for follicular lymphoma: a systematic literature review and meta-analysis
… Patients with follicular lymphoma (FL) can have high … /refractory (r/r) after ≥2 prior lines of
therapy (LOT), remission … would be censored for time-to-event analyses at the time of switch. …
therapy (LOT), remission … would be censored for time-to-event analyses at the time of switch. …
Prolonged clinical remissions in patients with relapsed or refractory follicular lymphoma treated with autologous stem cell transplantation incorporating rituximab
NL Berinstein, S Bhella, NM Pennell, MC Cheung… - Annals of …, 2015 - Springer
… time to death from enrolment was 58 months (range 11–135), with one death in the 90-day
peri-transplant period… -risk or recurrent/refractory follicular lymphoma undergoing HDT and …
peri-transplant period… -risk or recurrent/refractory follicular lymphoma undergoing HDT and …
… of allogeneic over autologous transplantation in patients with very early relapsed and refractory follicular lymphoma with prior remission duration of≤ 12 months
MA Lunning, JC Migliacci, P Hilden… - British journal of …, 2016 - Wiley Online Library
… to prior remission duration ≤12 months, (D) Overall Survival according to prior remission
duration ≤12 … We are the first to report remission duration of ≤12 months prior to re-induction …
duration ≤12 … We are the first to report remission duration of ≤12 months prior to re-induction …
How I treat early-relapsing follicular lymphoma
C Casulo, PM Barr - Blood, The Journal of the American Society …, 2019 - ashpublications.org
… at a later time point. On the basis of his young age and short remission duration, we suggested
… for patients with rituximab-refractory follicular lymphoma and warrants additional study in …
… for patients with rituximab-refractory follicular lymphoma and warrants additional study in …
High rate of durable complete remission in follicular lymphoma after CD19 CAR-T cell immunotherapy
AV Hirayama, J Gauthier, KA Hay… - Blood, The Journal …, 2019 - ashpublications.org
… remained in remission at a median follow-up of 24 months. The median duration of response
… Treatment of relapsed/refractory (R/R) large B-cell non-Hodgkin lymphoma (NHL) patients …
… Treatment of relapsed/refractory (R/R) large B-cell non-Hodgkin lymphoma (NHL) patients …
What is remission in follicular lymphoma and what is its relevance?
… monitor FL by molecular methods, clinical remission status and duration were and remain the
mainstay … in patients receiving combination chemotherapy treatment of follicular lymphoma. …
mainstay … in patients receiving combination chemotherapy treatment of follicular lymphoma. …
Treatment patterns and outcomes of patients with relapsed or refractory follicular lymphoma receiving three or more lines of systemic therapy (LEO CReWE): a …
C Casulo, MC Larson, JJ Lunde… - The Lancet …, 2022 - thelancet.com
… Novel therapies for relapsed or refractory follicular lymphoma … duration of response in patients
with relapsed or refractory … to more therapies that have longer remission. The presence of …
with relapsed or refractory … to more therapies that have longer remission. The presence of …
[HTML][HTML] Treatment patterns and outcomes in relapsed/refractory follicular lymphoma: results from the international SCHOLAR-5 study
… Moreover, the durability of remission with available treatments decreases with each … to
be longer than our maximum follow-up time. This in turn impedes naïve comparisons to other …
be longer than our maximum follow-up time. This in turn impedes naïve comparisons to other …
Therapy of relapsed or refractory low-grade follicular lymphomas: factors associated with complete remission, survival and time to treatment failure
JA Spinolo, F Cabanillas, DO Dixon, SM Khorana… - Annals of oncology, 1992 - Elsevier
… regimens for the treatment of patients with relapsed lymphoma. In an attempt to define factors
associated with complete remission rate, survival, and time to treatment failure (TTF) in this …
associated with complete remission rate, survival, and time to treatment failure (TTF) in this …
相关搜索
- relapsed or refractory follicular lymphoma
- refractory follicular lymphoma potential benefit
- patients with follicular lymphoma
- follicular lymphoma stem cell transplantation
- follicular lymphoma rituximab era
- treatment of follicular lymphoma
- low grade follicular lymphomas
- early progression of follicular lymphoma
- follicular lymphoma clinical outcomes
- follicular lymphoma modern era
- follicular lymphoma long term
- refractory follicular lymphoma autologous transplantation
- follicular lymphoma high dose therapy
- follicular lymphoma cohort study
- follicular lymphoma prior lines
- follicular lymphoma autologous stem cell transplant